Company Description
Doximity, Inc. operates as a digital platform for medical professionals in the United States.
Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.
The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.
The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.
Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jun 24, 2021 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 830 |
| CEO | Jeffrey Tangney |
Contact Details
Address: 500 3rd Street, Suite 510 San Francisco, California 94107 United States | |
| Phone | 650 549 4330 |
| Website | doximity.com |
Stock Details
| Ticker Symbol | DOCS |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| IPO Price | $26.00 |
| CIK Code | 0001516513 |
| CUSIP Number | 26622P107 |
| ISIN Number | US26622P1075 |
| Employer ID | 27-2485512 |
| SIC Code | 7371 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey A. Tangney | Co-Founder, Chief Executive Officer and Chairperson |
| Dr. Nathan Gross M.D. | Advisor and Co-Founder |
| Anna Bryson | Chief Financial Officer |
| Jennifer W. Chaloemtiarana J.D. | General Counsel and Corporate Secretary |
| Shari Buck | Co-founder and SVice President People and Ops |
| Jey Balachandran | Chief Technology Officer |
| Perry Scott Gold | Head of Investor Relations |
| Bruno Miranda | Senior Vice President of Engineering |
| Joel Davis | Senior Vice President of Product |
| Ben Greenberg | Senior Vice President and GM Commercial Products |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 8, 2025 | 144 | Filing |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Aug 7, 2025 | 8-K | Current Report |
| Aug 6, 2025 | SCHEDULE 13G/A | Filing |
| Aug 1, 2025 | 144 | Filing |
| Jul 16, 2025 | ARS | Filing |
| Jul 16, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 16, 2025 | DEF 14A | Other definitive proxy statements |
| Jul 11, 2025 | 144 | Filing |
| Jul 1, 2025 | 144 | Filing |